These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 18031092

  • 1. [Not Available].
    Holt DW, Johnston A.
    BioDrugs; 1997 Mar; 7(3):175-97. PubMed ID: 18031092
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
    Noble S, Markham A.
    Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
    Dunn CJ, Wagstaff AJ, Perry CM, Plosker GL, Goa KL.
    Drugs; 2001 Nov; 61(13):1957-2016. PubMed ID: 11708766
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
    Coukell AJ, Plosker GL.
    Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420
    [Abstract] [Full Text] [Related]

  • 5. A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features.
    Friman S, Bäckman L.
    Clin Pharmacokinet; 1996 Mar; 30(3):181-93. PubMed ID: 8882300
    [Abstract] [Full Text] [Related]

  • 6. Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion.
    Trull AK, Tan KK, Tan L, Alexander GJ, Jamieson NV.
    Br J Clin Pharmacol; 1995 Jun; 39(6):627-31. PubMed ID: 7654480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F, Marti HP, Frey FJ, Uehlinger DE.
    Clin Pharmacokinet; 2002 Jun; 41(1):59-69. PubMed ID: 11825097
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
    Hoyer PF.
    Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin pharmacokinetics in paediatric transplant recipients.
    Cooney GF, Habucky K, Hoppu K.
    Clin Pharmacokinet; 1997 Jun; 32(6):481-95. PubMed ID: 9195117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.